UPDATED 20.02.2014 13:12

Organised cervical cancer screening programme in Finland in the invitation year 2008. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 415 municipalities (out of 415).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 179299 1671 0.93 15 0.01 4 0.00 25 0.01 173 0.10 216 0.12 146 0.08 1092 0.61
I 167121 4 0.00 - - - - - - - - - - - - 4 0.00
II 10916 448 0.25 1 0.00 - - - - 15 0.01 9 0.01 32 0.02 391 0.22
III 1150 1124 0.63 7 0.00 3 0.00 12 0.01 121 0.07 197 0.11 104 0.06 680 0.38
IV 92 92 0.05 5 0.00 1 0.00 13 0.01 37 0.02 10 0.01 10 0.01 16 0.01
V 3 3 0.00 2 0.00 - - - - - - - - - - 1 0.00
Inadequate 5 - - - - - - - - - - - - - - - -
Unknown 12 - - - - - - - - - - - - - - - -
HPV test 15924 408 2.56 - - - - 9 0.06 26 0.16 78 0.49 34 0.21 261 1.64
Negative1 14288 4 0.03 - - - - - - - - 1 0.01 - - 3 0.02
Positive2 1636 404 2.54 - - - - 9 0.06 26 0.16 77 0.48 34 0.21 258 1.62
Total 195223 2079 1.06 15 0.01 4 0.00 34 0.02 199 0.10 294 0.15 180 0.09 1353 0.69

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.